Contents: SEMAGLUTIDE
Rybelsus® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes
mellitus to improve glycaemic control as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance or contraindication
- in combination with other medicinal products for the treatment of diabetes.